President Donald Trump has begun his second administration with a series of controversial moves and decisions.

The president has an ambitious economic plan, starting with trade, and doesn’t appear interested in negotiations—yet.

UK’s most valuable listed company raised NHS rejection of its new breast cancer drug and the drug pricing mechanism during negotiations ...